Effect of 2-h Infusion of ON 01910.Na in Ovarian Cancer Patients
NCT00856791
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
1
Enrollment
INDUSTRY
Sponsor class
Conditions
Ovarian Cancer
Interventions
DRUG:
ON 01910.Na
Sponsor
Traws Pharma, Inc.